The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The Canada bioresorbable polymers market is expected to exhibit a CAGR of 11% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.
A bioresorbable polymer refers to a class of materials that can be absorbed by the body and does not need any mechanical removal. Some of the commonly available bioresorbable polymers include polylactic acid, polyglycolide, polycaprolactone, polysaccharides, etc. They are usually manufactured from vegetable oils derived from rapeseed, sunflower corn fiber, food processing waste, potato, paper mill sludge, etc. Bioresorbable polymers offer various benefits, including lesser stiffness, precise material composition, enhanced microstructure control, etc. A range of physical and degradation properties enables these polymers to be utilized for numerous medical applications, such as tissue engineering, drug delivery, dental implants, orthopedic fixation, etc.
The escalating usage of bioresorbable polymers in biomedical settings, including prostheses, sutures, orthopedic surgeries, implants, etc., based on their enhanced dissolubility and faster healing, is primarily driving the Canada bioresorbable polymers market. Bioresorbable polymer-based implants also aid in improving patient care and clinical outcomes while avoiding complex medical procedures. Besides this, the expanding geriatric population in Canada, which is leading to the increasing incidences of osteoporosis and osteoarthritis, is creating a positive outlook for the regional market. Furthermore, the rising adoption of bioresorbable polymers in wound management, as they provide an excellent barrier against bacterial penetration and enhance oxygen permeability, is acting as another growth-inducing factor. Additionally, bioresorbable polymers are also utilized as an efficient drug carrier that allows regulated and consistent delivery of a variety of medicinal components, such as antibiotics and anti-cancer medications. Moreover, the emerging popularity of bioresorbable polymer powders for dermal filler procedures is further propelling the product demand in the region. In addition to this, the extensive application of bioresorbable polymers in the field of tissue engineering to develop organ-like structures via 3D scaffold printing is expected to drive the Canada bioresorbable polymers market in the coming years.
IMARC Group provides an analysis of the key trends in each sub-segment of the Canada bioresorbable polymers market report, along with forecasts for the period 2022-2027. Our report has categorized the market based on product, application and end use.
Breakup by Product
Breakup by Application
Breakup by End Use
The competitive landscape of the industry has also been examined with some of the key players being Ashland, Bezwada Biomedical LLC, Corbion, Evonik Industries, Foster Corporation, Polysciences, Inc., Putnam Plastics, and Zeus Industrial Products, Inc.
|Base Year of the Analysis||2021|
|Segment Coverage||Product, Application, End Use|
|Companies Covered||Ashland, Bezwada Biomedical LLC, Corbion, Evonik Industries, Foster Corporation, Polysciences, Inc., Putnam Plastics, and Zeus Industrial Products, Inc.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2699
Five User License: US$ 3699
Corporate License: US$ 4699
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at